Integer (NYSE:ITGR – Get Free Report) is expected to be releasing its Q3 2026 results before the market opens on Thursday, October 22nd. Analysts expect the company to post earnings of $1.68 per share and revenue of $456.91 million for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 9:00 AM ET.
Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. Integer’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.55 EPS. On average, analysts expect Integer to post $6.09 EPS for the current fiscal year and $6.71 EPS for the next fiscal year.
Integer Stock Performance
Shares of NYSE ITGR opened at $126.75 on Tuesday. The company has a market cap of $4.31 billion, a P/E ratio of 34.63, a P/E/G ratio of 2.41 and a beta of 0.58. Integer has a 52-week low of $62.00 and a 52-week high of $126.79. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. The firm’s fifty day moving average is $126.00 and its two-hundred day moving average is $104.84.
Insider Buying and Selling at Integer
In other Integer news, insider Andrew Senn sold 9,408 shares of Integer stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the completion of the transaction, the insider directly owned 5,405 shares of the company’s stock, valued at $682,651.50. The trade was a 63.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kirk K. Thor sold 11,767 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the transaction, the insider owned 7,153 shares in the company, valued at $902,923.19. This trade represents a 62.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 40,948 shares of company stock worth $5,169,920 in the last 90 days. 1.10% of the stock is currently owned by insiders.
Analyst Ratings Changes
Several brokerages have recently issued reports on ITGR. Raymond James Financial cut Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. Truist Financial downgraded shares of Integer from a “buy” rating to a “hold” rating and boosted their target price for the stock from $110.00 to $127.00 in a report on Monday, August 3rd. Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Monday, August 3rd. Finally, Piper Sandler downgraded shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target for the company. in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $109.86.
Read Our Latest Research Report on Integer
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.
Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.
Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.
Read More
- Five stocks we like better than Integer
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
